| # | Drug | Count |
|---|---|---|
| 0 | OXALIPLATIN | 598 |
| 1 | CAPECITABINE | 593 |
| 2 | FLUOROURACIL | 592 |
| 3 | FLUOROURACIL CREAM, 0.5% | 591 |
| 4 | ASPIRIN | 265 |
| 5 | ASPIRIN 325 MG | 258 |
| 6 | ASPIRIN 81 MG | 258 |
| 7 | PROPOFOL | 152 |
| 8 | SUMATRIPTAN | 142 |
| 9 | EPINEPHRINE | 134 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ACETYLCHOLINE CHLORIDE | 8 | 0.0816 |
| 1 | VECURONIUM BROMIDE | 34 | 0.0222 |
| 2 | DEXMEDETOMIDINE HYDROCHLORIDE | 64 | 0.0213 |
| 3 | METHYLERGONOVINE MALEATE | 11 | 0.0180 |
| 4 | ADENOSINE | 27 | 0.0166 |
| 5 | POLYETHYLENE GLYOCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE AND POTASSIUM CHLORIDE | 2 | 0.0161 |
| 6 | ISOPROTERENOL HYDROCHLORIDE | 7 | 0.0161 |
| 7 | EPHEDRINE SULFATE | 3 | 0.0137 |
| 8 | EPHEDRINE HYDROCHLORIDE | 5 | 0.0110 |
| 9 | DOBUTAMINE HYDROCHLORIDE | 13 | 0.0100 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nucleoside Metabolic Inhibitor [EPC] | 1172 |
| 1 | Platinum-based Drug [EPC] | 724 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 405 |
| 3 | Corticosteroid [EPC] | 307 |
| 4 | Platelet Aggregation Inhibitor [EPC] | 267 |
| 5 | Nitrate Vasodilator [EPC] | 222 |
| 6 | Dihydropyridine Calcium Channel Blocker [EPC] | 182 |
| 7 | General Anesthetic [EPC] | 170 |
| 8 | Catecholamine [EPC] | 157 |
| 9 | Proton Pump Inhibitor [EPC] | 153 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | alpha-1 Adrenergic Agonist [EPC] | 26 | 0.0059 |
| 1 | Adenosine Receptor Agonist [EPC] | 42 | 0.0057 |
| 2 | Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] | 115 | 0.0046 |
| 3 | CD38-directed Cytolytic Antibody [EPC] | 26 | 0.0044 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 1172 | 0.0043 |
| 5 | General Anesthetic [EPC] | 170 | 0.0039 |
| 6 | Vasoconstrictor [EPC] | 1 | 0.0033 |
| 7 | Interleukin-5 Antagonist [EPC] | 2 | 0.0029 |
| 8 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 24 | 0.0028 |
| 9 | Platinum-based Drug [EPC] | 724 | 0.0026 |